🇺🇸 FDA
Drug

pegcetacoplan

Brand: SYFOVRE

approved

Quick answer

pegcetacoplan (SYFOVRE), is a pharmaceutical active ingredient, associated with Apellis Pharmaceuticals, with approved status in the US.

Key facts

INN
pegcetacoplan
Brand
SYFOVRE
Route
SUBCUTANEOUS
Formulation
SOLUTION
Originator
Apellis Pharmaceuticals

Related news

FDA Approves Syfovre: First Treatment for Geographic Atrophy
NewsOphthalmologyMar 31, 2026

FDA Approves Syfovre: First Treatment for Geographic Atrophy

Syfovre has received FDA approval as the first-ever treatment for geographic atrophy, marking a significant advancement in managing this debilitating condition.

Dr. Sarah Mitchell

Frequently asked questions

What is pegcetacoplan?

pegcetacoplan (SYFOVRE), is a pharmaceutical active ingredient, associated with Apellis Pharmaceuticals, with approved status in the US.

What is the brand name for pegcetacoplan?

SYFOVRE is a marketed brand name for pegcetacoplan. Check FDA Drugs@FDA for the current US label holder.